New £30m initiative launched to support innovation against antimicrobial resistance
Global innovators can apply to PACE to receive up to £1m per project
Read More
Tag: Pathways to Antimicrobial Clinical Efficacy
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
